{"id":61925,"date":"2025-09-25T22:04:59","date_gmt":"2025-09-25T20:04:59","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/"},"modified":"2025-09-25T22:04:59","modified_gmt":"2025-09-25T20:04:59","slug":"healthmine-appoints-dwight-erskine-as-new-chief-executive-officer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/","title":{"rendered":"Healthmine Appoints Dwight Erskine as New Chief Executive Officer"},"content":{"rendered":"<div>\n<p>DALLAS&#8211;(BUSINESS WIRE)&#8211;Healthmine, a leading member engagement and rewards platform for health plans, today announced that its Board of Directors has appointed Dwight Erskine as its new Chief Executive Officer, effective September 15, 2025. Erskine succeeds Bryce Williams, who will remain with the company during a transition period before moving into an advisory role.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20250924447398\/en\/2588445\/5\/HM_Logo_Color.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250924447398\/en\/2588445\/22\/HM_Logo_Color.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250924447398\/en\/2588445\/5\/HM_Logo_Color.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250924447398\/en\/2588445\/21\/HM_Logo_Color.jpg\"><\/a><\/p>\n<p>\nErskine joins Healthmine as a seasoned leader with more than 25 years of experience in healthcare technology, transformation and analytics. He most recently served as Senior Vice President of Enterprise Transformation at VillageMD where he led the streamlining of clinical operations and scale value-based care delivery across the organization. Prior to that role, he was the healthcare leader at Synergetics, a global operations consulting firm, where he advised payers and providers on operational strategy, digital transformation and performance improvement. Throughout his career, he has focused on building sustainable solutions that improve patient care, reduce complexity and empower organizations to thrive in changing markets. He is widely recognized for blending innovative thinking with practical execution, ensuring bold ideas become measurable results.<\/p>\n<p>\n\u201cI\u2019m honored to step into the role of CEO,\u201d Erskine says. \u201cHealthmine is built on a powerful idea that when you engage people in meaningful ways, you can change their health and their lives. My vision is to build on that idea by expanding our technology, strengthening our partnerships and empowering our clients to achieve results that matter. Together, we will push beyond traditional boundaries to deliver healthier communities and a stronger healthcare system.\u201d<\/p>\n<p>\nErskine joins Healthmine after a year of accelerated growth for the company. In 2025 so far, Healthmine has launched:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nIndustry-leading <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.healthmine.com%2Fresources%2Fai-powered-scheduling-removes-barriers-to-care-saves-money&amp;esheet=54328481&amp;newsitemid=20250924447398&amp;lan=en-US&amp;anchor=AI-supported+patient+scheduling&amp;index=1&amp;md5=13a1e4e7871f7d4ab84b3878e869fc39\" rel=\"nofollow\" shape=\"rect\">AI-supported patient scheduling<\/a>, QRM Connect\u2122, eliminating barriers to PCP appointment scheduling and increasing gap closure.<\/li>\n<li>\nImproved in-home assessment connectivity to help members self-schedule at-home visits, drive members back to their PCPs and provide the necessary data to health plans in case of risk adjustment audits.<\/li>\n<li>\nA <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.healthmine.com%2Fresources%2Fnow-partnering-with-exact-sciences-to-help-payers-improve-crc-screening-rates&amp;esheet=54328481&amp;newsitemid=20250924447398&amp;lan=en-US&amp;anchor=strategic+partnership+with+Exact+Sciences&amp;index=2&amp;md5=43746c56420a51a4686d261fae845999\" rel=\"nofollow\" shape=\"rect\">strategic partnership with Exact Sciences<\/a> to facilitate the incentivization of at-home colorectal cancer screenings with Cologuard\u2122.<\/li>\n<li>\nRevamped reward and incentives programs to allow for better coordination across quality and risk teams, more flexible reward redemption for members and ensure it meets the highest data security and compliance standards on the market.<\/li>\n<li>\nA <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.healthmine.com%2Fresources%2Fhealthmine-and-tenasol-launch-real-time-adt-solution&amp;esheet=54328481&amp;newsitemid=20250924447398&amp;lan=en-US&amp;anchor=strategic+partnership+with+Tenasol&amp;index=3&amp;md5=c39724839834880618a53764156a7e6d\" rel=\"nofollow\" shape=\"rect\">strategic partnership with Tenasol<\/a> to deliver timely gap closure for the Transition of Care (TRC) and Follow-up After ED Visit for People with Multiple High-Risk Chronic Condition (FMC) Star Ratings measures.<\/li>\n<\/ul>\n<p>\n\u201cUnder Bryce\u2019s leadership, Healthmine has built a strong foundation and delivered significant value for health plans and members, especially under the intense regulatory scrutiny and change we\u2019ve seen over the last 10 years,\u201d says Charles Boorady, Founding Managing Partner at Health Catalyst Capital and Healthmine board member. \u201cWith Dwight stepping in, we see an exciting opportunity to expand the company\u2019s reach and impact. Dwight brings not just experience, but also the energy and vision needed to reimagine how technology and data can improve lives at scale.\u201d<\/p>\n<p>\n<b>About Healthmine<\/b><\/p>\n<p>\nHealthmine is the industry\u2019s leading member engagement solution, simplifying how health plans make the most of every member moment. Our SaaS-based, always-on Quality Relationship Management\u2122 (QRM<sup>\u00ae<\/sup>) platform eliminates data chasing so plans can capture whole views of each member. Our team of behavioral scientists and regulatory experts partner with each health plan to use this member-level detail to build personalized outreach that motivates members to take the right next step in their health journeys. With customized triggers based on clinical, pharmacy, CAHPS and HOS measures, and when paired with intelligent incentives, plans can see accelerated results in health equity and member outcomes while better managing medical spend and reducing the burden on their teams. Real-time data dashboards with actionable insights allow plans to act fast and better prioritize areas of opportunity to meet revenue and quality goals. Connect with us at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.healthmine.com%2F&amp;esheet=54328481&amp;newsitemid=20250924447398&amp;lan=en-US&amp;anchor=Healthmine.com&amp;index=4&amp;md5=58ac17b4e32b346c831958b687a07a1f\" rel=\"nofollow\" shape=\"rect\">Healthmine.com<\/a> and on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fhealthmine%2F&amp;esheet=54328481&amp;newsitemid=20250924447398&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=5&amp;md5=819aaa4ed3b5648cd942b176627c0c37\" rel=\"nofollow\" shape=\"rect\">LinkedIn<\/a>.<\/p>\n<p>\n<b>About Health Catalyst Capital<\/b><\/p>\n<p>\nHealth Catalyst Capital (HCC) invests in privately held healthcare technology and services businesses that aim to enhance care quality, access, and affordability. We leverage relationships with over 250 major healthcare and technology enterprises to identify sustainable investment themes. We co-invest alongside strategic partners, some of which are limited partners in our funds. HCC drives value creation by helping portfolio company management teams integrate AI into their operations and build commercial relationships that accelerate growth, including hundreds of direct introductions by HCC to prospective customers and partners.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nBrett Rudisill, Senior Vice President, Marketing, Healthmine<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;&#x74;&#111;:&#x42;&#114;&#x65;&#116;t&#x2e;&#82;&#x75;&#100;i&#x73;i&#x6c;&#108;&#x40;&#x48;e&#x61;&#108;&#x74;&#104;m&#x69;&#110;&#x65;&#46;c&#x6f;m\" rel=\"nofollow\" shape=\"rect\">&#66;&#x72;&#101;&#x74;t&#x2e;R&#117;&#x64;&#105;&#x73;i&#x6c;l&#64;&#x48;&#101;&#x61;l&#x74;h&#109;&#x69;&#110;&#x65;&#46;&#x63;o&#109;<\/a><br \/>717.324.5004<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DALLAS&#8211;(BUSINESS WIRE)&#8211;Healthmine, a leading member engagement and rewards platform for health plans, today announced that its Board of Directors has appointed Dwight Erskine as its new Chief Executive Officer, effective September 15, 2025. Erskine succeeds Bryce Williams, who will remain with the company during a transition period before moving into an advisory role. Erskine joins &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61925","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Healthmine Appoints Dwight Erskine as New Chief Executive Officer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Healthmine Appoints Dwight Erskine as New Chief Executive Officer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DALLAS&#8211;(BUSINESS WIRE)&#8211;Healthmine, a leading member engagement and rewards platform for health plans, today announced that its Board of Directors has appointed Dwight Erskine as its new Chief Executive Officer, effective September 15, 2025. Erskine succeeds Bryce Williams, who will remain with the company during a transition period before moving into an advisory role. Erskine joins ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-25T20:04:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250924447398\/en\/2588445\/22\/HM_Logo_Color.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Healthmine Appoints Dwight Erskine as New Chief Executive Officer\",\"datePublished\":\"2025-09-25T20:04:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\\\/\"},\"wordCount\":742,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250924447398\\\/en\\\/2588445\\\/22\\\/HM_Logo_Color.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\\\/\",\"name\":\"Healthmine Appoints Dwight Erskine as New Chief Executive Officer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250924447398\\\/en\\\/2588445\\\/22\\\/HM_Logo_Color.jpg\",\"datePublished\":\"2025-09-25T20:04:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250924447398\\\/en\\\/2588445\\\/22\\\/HM_Logo_Color.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250924447398\\\/en\\\/2588445\\\/22\\\/HM_Logo_Color.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Healthmine Appoints Dwight Erskine as New Chief Executive Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Healthmine Appoints Dwight Erskine as New Chief Executive Officer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/","og_locale":"en_US","og_type":"article","og_title":"Healthmine Appoints Dwight Erskine as New Chief Executive Officer - Pharma Trend","og_description":"DALLAS&#8211;(BUSINESS WIRE)&#8211;Healthmine, a leading member engagement and rewards platform for health plans, today announced that its Board of Directors has appointed Dwight Erskine as its new Chief Executive Officer, effective September 15, 2025. Erskine succeeds Bryce Williams, who will remain with the company during a transition period before moving into an advisory role. Erskine joins ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/","og_site_name":"Pharma Trend","article_published_time":"2025-09-25T20:04:59+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250924447398\/en\/2588445\/22\/HM_Logo_Color.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Healthmine Appoints Dwight Erskine as New Chief Executive Officer","datePublished":"2025-09-25T20:04:59+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/"},"wordCount":742,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250924447398\/en\/2588445\/22\/HM_Logo_Color.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/","url":"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/","name":"Healthmine Appoints Dwight Erskine as New Chief Executive Officer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250924447398\/en\/2588445\/22\/HM_Logo_Color.jpg","datePublished":"2025-09-25T20:04:59+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250924447398\/en\/2588445\/22\/HM_Logo_Color.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250924447398\/en\/2588445\/22\/HM_Logo_Color.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/healthmine-appoints-dwight-erskine-as-new-chief-executive-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Healthmine Appoints Dwight Erskine as New Chief Executive Officer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61925"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61925\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}